Liquidia Technologies (LQDA) Prices 9.375M Share Common Offering at $8/Sh

After-Hours Stock Movers 06/29: (XLNX) (MU) (LULU) Higher; (LQDA) (SYNC) (MLHR) Lower (more...)

After-Hours Stock Movers

Qumu Corporation (Nasdaq: QUMU) 18.8% HIGHER; Synacor and Qumu announced that the companies have mutually agreed to terminate their proposed all-stock merger agreement, previously announced on February 11, 2020.

Liquidia Technologies, Inc. (NASDAQ: LQDA) 18.1% LOWER; announced today that it has commenced an underwritten public offering of its common stock

Synacor, Inc. (Nasdaq: SYNC) 8% LOWER; Synacor and Qumu Corporation (Nasdaq: QUMU) announced that the companies have... More

Liquidia Technologies (LQDA) to Offer Common Stock

Liquidia Technologies, Inc. (NASDAQ: LQDA) announced today that it has commenced an underwritten public offering of its common stock. All of the shares in the proposed offering will be sold by Liquidia. In addition, Liquidia expects to grant the underwriters a standard 30-day... More

Liquidia Technologies (LQDA) Reports Acquisition of RareGen to Expand Presence in PAH

Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products using its proprietary PRINT® technology, announced it has entered into a definitive agreement to acquire RareGen, LLC, a portfolio company of PBM Capital, through an all-stock merger. Liquidia and RareGen will consolidate under a new holding company, to be named Liquidia Corporation, which is expected to trade on the Nasdaq Capital Market under the ticker symbol LQDA, as the successor to Liquidia Technologies. RareGen provides strategy, investment, and commercialization for rare disease pharmaceutical... More